T he cause of sudden cardiac death (SCD) in a young patient without any previous cardiac history can oftentimes be challenging, particularly if there are ≥2 equally plausible but improbable pathogenesis. As part of a thorough evaluation, electrophysiological, anatomic/functional, and genetic testing results may be illuminating but at other times can be misleading unless the nuances of test results and their interpretation are fully appreciated. We report a case of a patient who survived an out-of-hospital cardiac arrest after vigorous exercise and who was found to have a decrementally conducting Mahaim-like accessory pathway (AP), as well as a dilated right ventricle (RV) and a missense mutation identified in the plakophilin-2 (PKP2) gene. We examine the challenges of interpreting results of such screening tests and how to distinguish the probable pathogenesis of SCD when there are 2 competing findings, neither of which is entirely dispositive.
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Case
A 29-year-old white woman with multiple congenital anomalies, including coarctation of the aorta and bicuspid aortic valve, was admitted to the hospital after sudden cardiac arrest. Several years earlier, she was reported to have a transient irregular wide complex tachycardia thought to be because of preexcited atrial fibrillation (AF). On the day of presentation, she experienced abrupt syncope immediately after playing tennis. A bystander initiated cardiopulmonary resuscitation and delivered 2 shocks with an automatic external defibrillator ( Figure 1 ). Emergency medical services arrived shortly afterward and delivered an additional external shock, resulting in a return of spontaneous circulation. Rhythm strips shortly after resuscitation showed an irregular rhythm with a narrow complex configuration and runs of an irregular rhythm with a wide complex morphology. She was brought to her local emergency room where her initial laboratory studies were all within normal limits. A toxicology screen was negative. A 12-lead ECG showed sinus bradycardia at 38 beats per minute with a short PR interval and anterior T-wave inversion in leads V1 and V2 (Figure 2A ). The QT interval was normal. She received intravenous amiodarone on admission, but this was discontinued because of QT prolongation. She was transferred to our hospital for further care. When she regained consciousness and lucidity, she reported a history of monthly palpitations, lasting between 5 and 30 minutes, not associated with lightheadedness. She denied the use of any recreational drugs before the event. Her only medication was gabapentin. There was no previous history of syncope or family history of syncope, SCD, or heart disease.
Although the patient's baseline ECG showed no evidence for preexcitation, hospital telemetry recorded an occasional atrial bigeminal pattern associated with aberrancy or preexcitation of the premature beat ( Figure 2B ). An echocardiogram demonstrated normal left ventricular size and function and moderate tricuspid regurgitation. Cardiac MRI revealed normal left ventricular size and function with an ejection fraction of 70%. The RV was mild to moderately dilated (RV end-diastolic volume indexed to body surface area, 95 mL/m 2 ) but demonstrated normal RV systolic function. There was no evidence of myocardial infarction or scar, no evidence of infiltrative cardiomyopathy based on delayed enhancement MRI, and no evidence of myocardial fatty infiltration. Her coronary arteries were patent, and there were no coronary anomalies.
Given the patient's history of possible preexcitation and cardiac arrest of unclear pathogenesis, she underwent an invasive electrophysiology study. Pacing from the right ventricle demonstrated concentric retrograde atrial activation, consistent with conduction through the atrioventricular (AV) node, as well as retrograde dual AV nodal physiology. Pacing from the right atrium demonstrated anterograde dual AV nodal physiology and manifest preexcitation suggestive of a rightsided AP. The pathway conducted in the anterograde direction only with retrograde activation proceeding over the AV node. The conduction properties of the AP were consistent with a decremental or Mahaim-like pathway because the stimulus-to-delta wave interval increased during rapid atrial pacing ( Figure 3A ) and pathway conduction was abolished in response to adenosine (18 mg; Figure 3B ). In the baseline state, conduction over the AP blocked at an atrial paced cycle length of 410 ms ( Figure 3C ). The refractory period of the AP was ≤240 ms. Burst pacing from the right atrium failed to induce AF during the baseline state; however, during concurrent isoproterenol infusion (2 μg/min), preexcited AF was initiated, which was associated with hypotension ( Figure 4A ). The mean cycle length was 310 ms and the shortest preexcited RR interval was 240 ms.
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A sustained wide complex tachycardia with a cycle length of 365 ms was initiated with rapid atrial pacing from the high right atrium during isoproterenol infusion 2 μg/min ( Figure 4B ). An early premature atrial premature beat delivered simultaneously with septal atrial depolarization (recorded by the His bundle catheter) advanced the following ventricular beat, as well as the tachycardia, thus confirming the diagnosis of antidromic reciprocating tachycardia ( Figure 5A ). Ventriculoatrial activation and timing during antidromic reciprocating tachycardia and ventricular pacing were identical, suggesting that the retrograde limb of the tachycardia was the AV node and ruling out the possibility of atrioventricular nodal reentrant tachycardia with the AP serving as a passive bystander ( Figure 5B ). During tachycardia, retrograde conduction alternated between the AV nodal fast pathway (shorter cycle length; Figure 6A ) and the AV nodal slow pathway (longer cycle length; Figure 6B ).
During antidromic reciprocating tachycardia, earliest ventricular activation was observed along the lateral tricuspid annulus, with presystolic activation ( Figure 7A ) preceding RV apical activation, indicative of a short decremental atrioventricular pathway rather than a long Mahaim pathway inserting into right bundle or RV apical myocardium. Pacing at the site of earliest tricuspid annular site produced an identical QRS morphology match to that of antidromic reciprocating tachycardia ( Figure 7B ). Radiofrequency ablation performed at the site of earliest ventricular activation at this site terminated the tachycardia ( Figure 7C and 7D) and abolished AP conduction.
Programmed stimulation with up to triple extrastimuli introduced after 2 different cycle lengths (600 and 400 ms, respectively) delivered from the RV apex and the RV outflow tract in the baseline state did not induce any sustained ventricular arrhythmias.
Because the patient had a decremental AP consistent with a short AV Mahaim-like pathway, a finding not typically associated with SCD, it remained uncertain whether this was the primary cause of cardiac arrest. Therefore, additional testing was performed. Provocative testing with epinephrine and procainamide infusions was unremarkable and an exercise treadmill test was normal. In the absence of a conclusive pathogenesis of SCD, an implantable cardioverter-defibrillator was implanted for secondary prevention.
However, it remained imperative to still seek a primary cause to minimize the risk of future arrhythmia recurrences and enable appropriate evaluation of family members who may be at risk of an inheritable disorder. The presence of an abnormal cardiac MRI finding, a dilated right ventricle, raised the possibility of occult arrhythmogenic RV cardiomyopathy (ARVC). Therefore, further investigation was sought and screening with genetic testing was performed. Genetic testing (Familion, Omaha, NE) for ARVC identified a mutation in the PKP2 gene. The test reported positive for PKP2 Asn 517 Ser and was interpreted as positive for a variant of uncertain significance. Genetic testing did not reveal any mutations for long QT syndrome (LQTS), Brugada syndrome, or catecholaminergic ventricular tachycardia.
Discussion
The challenge in our patient was that there were 2 positive findings that could potentially explain the cause of cardiac arrest. However, neither explanation was completely sufficient. The association of sudden death with a nondecremental AP is uncommon, but the risk becomes indiscernible if the pathway is a decremental Mahaim-like pathway. Similarly, although the triad of exercise, ARVC, and malignant ventricular arrhythmias is well known, the significance of a missense mutation in a gene known to be responsible for the disease, but found in a patient without a fully expressed phenotype is unsettled.
A compilation of causes of sudden cardiac arrest because of ventricular fibrillation (VF) in a young patient (aged <40 years) includes primary myocardial processes (ie, hypertrophic cardiomyopathy, sarcoidosis, and myocarditis), coronary ischemia (ie, anomalous coronary arteries), or heritable channelopathies. 1 However, relevant to our patient, cardiac arrest occurred during exercise and in the absence of coronary artery disease or left ventricular dysfunction. Therefore, the possibilities include LQTS (especially type 1, LQT1), 2 catecholaminergic ventricular tachycardia, 3 Brugada syndrome (less commonly), 4 subclinical or concealed ARVC, 5 and ventricular preexcitation because of the Wolff-Parkinson-White syndrome. 6 The incidence of SCD in patients with Wolff-Parkinson-White syndrome is low and has been estimated to be 0.15% to 0.39% during 3-to 10-year follow-up. 7 Several risk factors are thought to identify patients who are at higher risk of sudden death, such as a short anterograde refractory period of the AP and an RR interval during preexcited AF <250 ms in the baseline state. 6 Male sex, the presence of multiple APs, and a history of supraventricular tachycardia are also associated with VF.
Our patient had a short atrioventricular decrementally conducting AP that was adenosine-sensitive and which was capable of anterograde conduction only. Such uncommon variants of preexcitation represent only 3% of all APs and are generally thought to be benign. 8 In contrast to patients with nondecremental APs, decremental Mahaim-like APs are not typically known to cause SCD. Indeed, only 4 associated cases exist in the literature. 9, 10 Although our patient demonstrated a relatively short refractory period of the AP, the significance of this finding has to be understood in its larger context (the pathway was decremental, adenosine-sensitive, and blocked during atrial pacing at a cycle length of 410 ms). Therefore, in the absence of compelling data linking Mahaim-like pathways to SCD, it remains imperative to still seek alternative causes to minimize the risk of future arrhythmia recurrences and enable appropriate evaluation of family members who may be at risk of an inheritable disorder.
The current Heart Rhythm Society/European Heart Rhythm Association expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies recommends that genetic testing for survivors of an unexplained out-of-hospital cardiac arrest should be guided by the results of medical evaluation and used for the primary purpose of screening at-risk family members for subclinical disease. 11 Routine genetic testing, in the absence of a clinical index of suspicion for a specific cardiomyopathy or channelopathy, is not indicated for the survivor of an unexplained out-of-hospital cardiac arrest.
Approximately, one third of cases of SCD in young patients cannot be explained by conventional medial autopsies. 12 However, postmortem genetic testing has identified cardiac e60 Circ Arrhythm Electrophysiol August 2013 channelopathies, such as LQTS and catecholaminergic ventricular tachycardia, as common pathogenesis in patients without structural heart disease. 13 Such additional testing may yield a clinical diagnosis in >50% of apparent unexplained cardiac arrests. In our case, targeted genetic testing to identify potential molecular causes of exercise-induced cardiac arrest (including genes for heritable channelopathies and cardiomyopathies such as LQTS, catecholaminergic ventricular tachycardia, Brugada syndrome, and ARVC) resulted in an indefinite finding. With the advent and ubiquity of commercial genetic testing, it is essential to recognize several key limitations when interpreting the results of such screening. Distinguishing whether a mutation of uncertain significance is causative or benign is critical for identifying appropriate therapy and prognosis while avoiding inappropriate labeling of a patient and his/her family with a genetic disease.
Genetic screening in our patient revealed a single-nucleotide substitution that encoded a change in an amino acid, a missense mutation. A missense mutation may result in a functionally altered protein associated with a pathological phenotype or be of no clinical consequence. The critical issue is how to assess the functional consequences of such a finding.
Clinical significance is determined by several factors: biochemical and biophysical properties of the substituted amino acid (ie, polar versus nonpolar, negative versus positive charge), topology (hot spots), residue conservation across species, and the race/ethnicity of the patient. Missense mutations in highly conserved residues of a gene are more likely to be pathogenic.
With regard to the missense mutation in our patient, asparagine and serine each has polar uncharged side chains. Using the PolyPhen (polymorphism phenotyping) automated sequence alignment server (http://genetics.bwh.harvard.edu/ pph), the amino acid residue corresponding to our patient's mutation is not conserved and, in fact, the mutated residue is also observed in the Xenopus tropicalis (Western clawed frog) species, suggesting that it is well tolerated. Analyzing the structural consequence of a suspected amino acid variant can help in determining its pathogenicity. 14 A mutation should be differentiated from a polymorphism. A mutation is a change in DNA sequence that occurs in <1% of the population and may or may not result in an abnormal protein product that has functional consequence. A polymorphism is a single-nucleotide substitution that occurs at given locus with a frequency ≥1%. Although often considered a normal variant and benign, this is not always the case because polymorphisms can have modifying effects on therapeutic agents or other disease states.
The functional significance of a given missense mutation can in part be assessed by knowing the degree of background genetic variation for the gene. To that end, ≈16% of normal controls (unadjusted for ethnicity) have missense mutations identified in any of the 5 major genes associated with ARVC. 15 This compares with a background mutation rate for LQTS of 6%. 16 Although some mutations would be expected to be more pathological than others, that is, nonsense mutations (which result in a premature stop codon), in-frame and frame-shift insertions and deletions, and mutations involving splice junctions, missense mutations cannot be readily dismissed as inconsequential, as they still account for ≈21% of known pathogenic ARVC mutations. 15 Our patient's phenotype was nonspecific and, therefore, uninformative. However, some subjects have a concealed phase of ARVC whereby VF is the first manifestation of the disease. 5 Although there was no family history of SCD or ARVC, the disease is associated with incomplete penetrance (likelihood that a mutation will be expressed) and variable expressivity (degree of phenotypic expression). Furthermore, ≈50% of cases are sporadic, having no familial lineage.
The results of genetic testing should be interpreted in an appropriate context, beginning with an understanding that the results are not binary: disease versus no disease. Rather, the results should be understood in the context of a continuum and statistical likelihood. 17 Therefore, statistically, missense mutations are less likely to be disease producing than insertion/ deletion and nonsense mutations, and in the case of missense mutations for certain channelopathies such as LQTS, location is predictive (ie, transmembrane domain, preregion, C terminus). 18 Similarly, mutations in PKP2 do not segregate at a particular locus, unlike mutations in other genes responsible for ARVC (ie, desmoplakin and desmoglein).
As a result of ongoing genomic studies, several algorithms have been proposed to assist in the interpretation of genetic testing. 15, 18 Future directions may consist of detailed functional in vitro and in vivo analyses to determine the pathogenicity of a particular mutation. With the expanding indication and commercial availability of genetic testing for channelopathies and cardiomyopathies, the clinician should be well informed about the limitations of such tests and appreciate the concept of benign genetic background noise. Interpretation should be guided by these caveats, as well as by careful phenotyping of the proband, and when used properly can assist in screening at-risk family members for subclinical disease. When confronted with a challenging case, referral to a clinical geneticist should be considered.
In our patient, the genetic test result of a variant of uncertain significance is likely benign. It remains possible that over time that, because of age-related expressivity, a clearer phenotypic picture may emerge, particularly if she develops a greater degree of RV dilation or dysfunction, epsilon waves, or precordial T-wave inversions on her ECG. 5 However, in the absence of these developments, the most probable cause of exercise-induced sudden death in our patient remains VF, resulting from the devolution of AF associated with conduction over a decremental AP.
Disclosures
None. 
